Commentary

How mental health care would look under a Trump vs. Biden administration


 

During his 2020 presidential campaign, Mr. Biden has suggested creating universal background checks and reinstating bans on assault rifle sales. He has said that he is also open to having a federal buyback program for assault rifles from gun owners.

Why this matters

The winner of the 2020 election will lead an electorate that is reeling from the health, economic, and social consequences COVID-19. The next administration needs to act swiftly to address the mental health pandemic and have a keen awareness of what is ahead. As Americans make their voting decision, consider who has the best plans not only to contain the virus but also the mental health crises that are ravaging our nation.

Dr. Vasan is a clinical assistant professor of psychiatry at Stanford (Calif.) University, where she is founder and executive director of Brainstorm: The Stanford Lab for Mental Health Innovation. She also serves as chief medical officer of Real, and chair of the American Psychiatric Association Committee on Innovation. Dr. Vasan has no conflicts of interest. Mr. Agbafe is a fellow at Stanford Brainstorm and a first-year medical student at the University of Michigan, Ann Arbor. He has no conflicts of interest. Ms. Li is a policy intern at Stanford Brainstorm and an undergraduate student in the department of economics at the University of California, Berkeley. She has no conflicts of interest.

Pages

Recommended Reading

Tocilizumab stumbles as COVID-19 treatment, narrow role possible
Federal Practitioner
COVID frontline physicians afraid to seek mental health care
Federal Practitioner
Chinese American families suffer discrimination related to COVID-19
Federal Practitioner
COVID-19 diagnosed on CTA scan in stroke patients
Federal Practitioner
Skin symptoms common in COVID-19 ‘long-haulers’
Federal Practitioner
Two COVID-19 outpatient antibody drugs show encouraging results
Federal Practitioner
CDC panel takes on COVID vaccine rollout, risks, and side effects
Federal Practitioner
About 17% of COVID-19 survivors retest positive in follow-up study
Federal Practitioner
Med student’s cardiac crisis a COVID-era medical mystery
Federal Practitioner
Biologics may protect psoriasis patients against severe COVID-19
Federal Practitioner